I agree that this site is using cookies. You can find further informations here.
X
Mielke, Orell
62  results:
Search for persons X
?
1

Analysis of relapse by inflammatory Rasch‐built overall dis..:

Merkies, Ingemar S. J. ; van Schaik, Ivo N. ; Bril, Vera...
Journal of the Peripheral Nervous System.  27 (2022)  2 - p. 159-165 , 2022
Link: https://doi.org/10.1111/..
 
?
2

TH-120. Electrophysiological predictors of response to subc..:

Alcantara, Monica ; Hartung, Hans-Peter ; Lawo, John-Philip...
Clinical Neurophysiology.  141 (2022)  - p. S114-S115 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Incidence and risk factors for intravenous immunoglobulin‐r..:

Cuesta, Hillary ; El Menyawi, Ibrahim ; Hubsch, Alphonse...
Transfusion.  62 (2022)  9 - p. 1894-1907 , 2022
Link: https://doi.org/10.1111/..
 
?
4

Electrophysiological predictors of response to subcutaneous..:

Alcantara, Monica ; Hartung, Hans-Peter ; Lawo, John-Philip...
Clinical Neurophysiology.  132 (2021)  9 - p. 2184-2190 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Pharmacometric analysis linking immunoglobulin exposure to ..:

Tortorici, Michael A. ; Yuraszeck, Theresa ; Cornblath, David...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  8 - p. 839-850 , 2021
Link: https://doi.org/10.1002/..
 
?
6

Duration and temporal dispersion measurements in CIDP subje..:

Menon, Deepak ; Vijayan, Joy ; Lawo, John-Philip...
RRNMF Neuromuscular Journal.  2 (2021)  3 - p. , 2021
Link: https://doi.org/10.17161..
 
?
7

Electrophysiological testing in chronic inflammatory demyel..:

Bril, Vera ; Hartung, Hans-Peter ; Lawo, John-Philip..
Clinical Neurophysiology.  132 (2021)  1 - p. 226-231 , 2021
Link: https://doi.org/10.1016/..
 
?
8

19. Pharmacokinetic modelling and simulation of flexible do..:

Ma, Xuewen ; Lewis, Richard A. ; Cornblath, David R....
Clinical Neurophysiology.  131 (2020)  3 - p. e8-e9 , 2020
Link: https://doi.org/10.1016/..
 
?
9

17. Benefit-Risk Profile of Intravenous Immunoglobulin (IVI..:

Shebl, Amgad ; Durn, Billie L. ; Bril, Vera...
Clinical Neurophysiology.  131 (2020)  3 - p. e7-e8 , 2020
Link: https://doi.org/10.1016/..
 
?
10

18. Secondary endpoints (PATH extension study): Long-term o..:

van Schaik, Ivo N. ; Mielke, Orell ; Bril, Vera...
Clinical Neurophysiology.  131 (2020)  3 - p. e8 , 2020
Link: https://doi.org/10.1016/..
 
?
11

21. Exposure-response of serum IgG levels and INCAT scores ..:

Yuraszeck, Theresa ; Lewis, Richard A. ; Cornblath, David R....
Clinical Neurophysiology.  131 (2020)  3 - p. e9-e10 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Placebo effect in chronic inflammatory demyelinating polyne..:

Lewis, Richard A. ; Cornblath, David R. ; Hartung, Hans‐Peter...
Journal of the Peripheral Nervous System.  25 (2020)  3 - p. 230-237 , 2020
Link: https://doi.org/10.1111/..
 
?
13

Long-term Safety and Efficacy of Subcutaneous Immunoglobuli..:

van Schaik, Ivo N. ; Mielke, Orell ; Bril, Vera...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
14

Benefit-Risk Profile of Intravenous Immunoglobulin (IVIG) a..:

Shebl, Amgad ; Durn, Billie L. ; Bril, Vera...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
15

Placebo Effect in the PATH Study of Subcutaneous Immunoglob..:

Lewis, Richard A. ; Bril, Vera ; van Geloven, Nan...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
1-15